Inhibition of glycogen synthase kinase-3β attenuates acute kidney injury in sodium taurocholate‑induced severe acute pancreatitis in rats

Zhao,Kailiang; Chen,Chen; Shi,Qiao; Deng,Wenhong; Zuo,Teng; He,Xiaobo; Liu,Tianyi; Zhao,Liang; Wang,Weixing

doi:10.3892/mmr.2014.2650

Inhibition of glycogen synthase kinase-3β attenuates acute kidney injury in sodium taurocholate‑induced severe acute pancreatitis in rats

Authors:
- Kailiang Zhao
- Chen Chen
- Qiao Shi
- Wenhong Deng
- Teng Zuo
- Xiaobo He
- Tianyi Liu
- Liang Zhao
- Weixing Wang
View Affiliations

Affiliations: Department of Hepatobiliary and Laparoscopic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: October 15, 2014 https://doi.org/10.3892/mmr.2014.2650
Pages: 3185-3192

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the efficacy of 4‑benzyl‑2‑methyl‑1,2,4‑thiadiazolidine‑3,5‑dione (TDZD‑8), the selective inhibitor of glycogen synthase kinase‑3β (GSK‑3β), on the development of acute kidney injury in an experimental model of sodium taurocholate‑induced severe acute pancreatitis (SAP) in rats. The serum amylase, lipase, interleukin‑1β and interleukin‑6 levels, and the pancreatic pathological score were examined to determine the magnitude of pancreatitis injury. The serum creatinine and blood urea nitrogen levels, myeloperoxidase (MPO) activity and renal histological grading were measured to assess the magnitude of SAP‑induced acute kidney injury. The activation of nuclear factor‑κB (NF‑κB) was examined using an immunohistochemistry assay. The expression of GSK‑3β, phospho‑GSK‑3β (Ser9), tumour necrosis factor‑α (TNF‑α), intercellular adhesion molecule‑1 (ICAM‑1) and inducible nitric oxide synthase (iNOS) protein in the kidney was characterised using western blot analysis. TDZD‑8 attenuated (i) serum amylase, lipase and renal dysfunction; (ii) the serum concentrations of proinflammatory cytokines; (iii) pancreatic and renal pathological injury; (iv) renal MPO activity and (v) NF‑κB activation and TNF‑α, ICAM‑1 and iNOS protein expression in the kidney. The results obtained in the present study suggest that the inhibition of GSK‑3β attenuates renal disorders associated with SAP through the inhibition of NF‑κB activation and the downregulation of the expression of proinflammatory cytokines, TNF‑α, ICAM‑1 and iNOS in rats. Blocking GSK‑3β protein kinase activity may be a novel approach to the treatment of this inﬂammatory condition.

View Figures

View References

1	Mitchell RMS, Byrne MF and Baillie J: Pancreatitis. Lancet. 361:1447–1455. 2003. View Article : Google Scholar
2	Kylänpää ML, Repo H and Puolakkainen PA: Inflammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol. 16:2867–2872. 2010.
3	Compañy L, Sáez J, Martínez J, et al: Factors predicting mortality in severe acute pancreatitis. Pancreatology. 3:144–148. 2003.
4	Li H, Qian ZX, Liu ZL, Liu XL, Han XT and Kang H: Risk factors and outcome of acute renal failure in patients with severe acute pancreatitis. J Crit Care. 25:225–229. 2010. View Article : Google Scholar : PubMed/NCBI
5	Papachristou GI, Clermont G, Sharma A, Yadav D and Whitcomb DC: Risk and markers of severe acute pancreatitis. Gastroenterology Clin North Am. 36:277–296. 2007. View Article : Google Scholar : PubMed/NCBI
6	Raraty MG and Neoptolemos JP: Compartments that cause the real damage in severe acute pancreatitis. American Journal of Respiratory and Critical Care Medicine. 168:141–142. 2003. View Article : Google Scholar
7	Woodgett JR: Judging a protein by more than its name: GSK-3. Sci STKE. 2001:re122001.PubMed/NCBI
8	Duarte AI, Santos P, Oliveira CR, Santos MS and Rego AC: Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression. Biochim Biophys Acta. 1783:994–1002. 2008. View Article : Google Scholar
9	Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC and Cleary ML: Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature. 455:1205–1229. 2008. View Article : Google Scholar : PubMed/NCBI
10	Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O and Woodgett JR: Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappa B activation. Nature. 406:86–90. 2000. View Article : Google Scholar : PubMed/NCBI
11	Cuzzocrea S, Malleo G, Genovese T, et al: Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice. Crit Care Med. 35:2811–2821. 2007. View Article : Google Scholar : PubMed/NCBI
12	Cuzzocrea S, Di Paola R, Mazzon E, et al: Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice. Shock. 27:97–107. 2007. View Article : Google Scholar : PubMed/NCBI
13	Chen H, Yang S, Yang Z, et al: Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration. J Cell Biochem. 102:1281–1289. 2007. View Article : Google Scholar : PubMed/NCBI
14	Dugo L, Collin M, Allen DA, et al: GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit Care Med. 33:1903–1912. 2005. View Article : Google Scholar : PubMed/NCBI
15	Cuzzocrea S, Genovese T, Mazzon E, et al: Glycogen synthase kinase-3beta inhibition attenuates the development of bleomycin-induced lung injury. Int J Immunopathol Pharmacol. 20:619–630. 2007.PubMed/NCBI
16	Cuzzocrea S, Mazzon E, Esposito E, et al: Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut. Intensive Care Med. 33:880–893. 2007. View Article : Google Scholar : PubMed/NCBI
17	Cuzzocrea S, Mazzon E, Di Paola R, et al: Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clin Immunol. 120:57–67. 2006. View Article : Google Scholar : PubMed/NCBI
18	Schmidt J, Rattner DW, Lewandrowski K, et al: A better model of acute pancreatitis for evaluating therapy. Ann Surg. 215:44–56. 1992. View Article : Google Scholar : PubMed/NCBI
19	Paller MS, Hoidal JR and Ferris TF: Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 74:1156–1164. 1984. View Article : Google Scholar : PubMed/NCBI
20	Yu J, Deng W, Wang W, et al: Inhibition of poly(ADP-ribose) polymerase attenuates acute kidney injury in sodium taurocholate-induced acute pancreatitis in rats. Pancreas. 41:1299–1305. 2012. View Article : Google Scholar : PubMed/NCBI
21	Donnahoo KK, Meng XZ, et al: Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J. 277:R922–R929. 1999.
22	Cuzzocrea S, Crisafulli C, Mazzon E, et al: Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice. Br J Pharmacol. 149:687–702. 2006. View Article : Google Scholar : PubMed/NCBI
23	Dugo L, Abdelrahman M, et al: Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation. Shock. 25:485–491. 2006. View Article : Google Scholar : PubMed/NCBI
24	Deng HB, Zhang N, Wang Y, et al: S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β. Exp Cell Res. 318:2592–2603. 2012.PubMed/NCBI
25	Wenhong D1, Jia Y, Weixing W, et al: Zerumbone attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury. Mediators Inflamm. 2012:1565072012. View Article : Google Scholar : PubMed/NCBI
26	Shi C, Zhao X, Wang X and Andersson R: Role of nuclear factor-kappaB, reactive oxygen species and cellular signaling in the early phase of acute pancreatitis. Scand J Gastroenterol. 40:103–108. 2005. View Article : Google Scholar : PubMed/NCBI
27	Altavilla D, Famulari C, Passaniti M, et al: Lipid peroxidation inhibition reduces NF-kappaB activation and attenuates cerulein-induced pancreatitis. Free Radic Res. 37:425–435. 2003. View Article : Google Scholar : PubMed/NCBI
28	Ahn DW, Ryu JK, Kim J, et al: Inflexinol reduces severity of acute pancreatitis by inhibiting nuclear factor-κB activation in cerulein-induced pancreatitis. Pancreas. 42:279–284. 2013.PubMed/NCBI
29	Hashimoto K, Ethridge RT, Saito H, Rajaraman S and Evers BM: The PPARgamma ligand, 15d-PGJ(2), attenuates the severity of cerulein-induced acute pancreatitis. Pancreas. 27:58–66. 2003. View Article : Google Scholar : PubMed/NCBI
30	Virlos L, Mazzon E, Serraino I, et al: Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis. Shock. 20:544–550. 2003. View Article : Google Scholar : PubMed/NCBI
31	De Ketelaere A, Vermeulen L, Vialard J, et al: Involvement of GSK-3beta in TWEAK-mediated NF-kappaB activation. FEBS Letters. 566:60–64. 2004.PubMed/NCBI
32	Kumar A, Takada Y, Boriek AM and Aggarwal BB: Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl). 82:434–448. 2004. View Article : Google Scholar : PubMed/NCBI
33	Martin M, Rehani K, Jope RS and Michalek SM: Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 6:777–784. 2005. View Article : Google Scholar : PubMed/NCBI
34	Sendler M, Dummer A, Weiss FU, et al: Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice. Gut. 62:430–439. 2013.
35	Takada Y, Fang XJ, Jamaluddin MS, Boyd DD and Aggarwal BB: Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J Bio Chem. 279:39541–39554. 2004. View Article : Google Scholar
36	Yu J, Xu S, Wang WX, et al: Changes of inflammation and apoptosis in adrenal gland after experimental injury in rats with acute necrotizing pancreatitis. Inflammation. 35:11–22. 2012. View Article : Google Scholar : PubMed/NCBI
37	Chen C, Xu S, Wang WX, et al: Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Arch Med Res. 40:79–88. 2009. View Article : Google Scholar : PubMed/NCBI
38	Genovese T, Mazzon E, Di Paola R, et al: Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice. Shock. 25:161–167. 2006. View Article : Google Scholar : PubMed/NCBI
39	Mazzon E, Impellizzeri D, Di Paola R, et al: Effects of mitogen-activated protein kinase signaling pathway inhibition on the development of cerulein-induced acute pancreatitis in mice. Pancreas. 41:560–570. 2012. View Article : Google Scholar : PubMed/NCBI
40	Cuzzocrea S, Mazzon E, Dugo L, et al: Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock. 17:416–422. 2002. View Article : Google Scholar : PubMed/NCBI
41	Satoh A, Shimosegawa T, Kimura K, et al: Nitric oxide is overproduced by peritoneal macrophages in rat taurocholate pancreatitis: the mechanism of inducible nitric oxide synthase expression. Pancreas. 17:402–411. 1998. View Article : Google Scholar : PubMed/NCBI